Lopressor and Lamisil drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lopressor (metoprolol tartrate) and Lamisil (terbinafine hydrochloride). Common drug interactions include cardiac failure congestive among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Lopressor and Lamisil. It is created by eHealthMe based on reports of 55 people who take the same drugs from the FDA, and is updated regularly.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.

What is Lamisil?

Lamisil has active ingredients of terbinafine hydrochloride. It is often used in pulmonary aspergilloma (mycetoma). eHealthMe is studying from 14,080 Lamisil users. Check the latest studies of Lamisil.



On Jul, 09, 2026

55 people who take Lopressor and Lamisil together, and have interactions are studied.

Lopressor and Lamisil drug interactions.

What are the common drug interactions of Lopressor and Lamisil, by gender? *:

female:

  1. Cardiac failure congestive
  2. Coma (state of unconsciousness lasting more than six hours)
  3. Complex regional pain syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet))
  4. Depression
  5. Diarrhoea
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Erythema (redness of the skin)
  8. Eye pruritus (eye itching)
  9. Ill-defined disorder
  10. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)

male:

  1. Fall
  2. Anxiety
  3. Depression
  4. Drug ineffective
  5. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  6. Nausea (feeling of having an urge to vomit)
  7. Anaemia (lack of blood)
  8. Arthralgia (joint pain)
  9. Bradycardia (abnormally slow heart action)
  10. Bronchitis chronic (inflammation of the mucous membrane in the bronchial tubes- chronic)

What are the common drug interactions of Lopressor and Lamisil, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Eye pruritus (eye itching)
  2. Drug ineffective
  3. Eye irritation
  4. Eye pain
  5. Pain
  6. Pruritus (severe itching of the skin)

40-49:

  1. Aggression
  2. Catatonia (unresponsive to external stimuli)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Food poisoning (poison in food)
  5. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  6. Hypernatraemia (an abnormally high plasma concentration of sodium ions)
  7. Impaired work ability
  8. Moaning (a low, sustained, mournful cry)
  9. Nausea (feeling of having an urge to vomit)
  10. Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)

50-59:

  1. Chills (felling of cold)
  2. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  3. Constipation
  4. Depression
  5. Disturbance in attention
  6. Drug dependence
  7. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  8. Dyspepsia (indigestion)
  9. Fatigue (feeling of tiredness)
  10. Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)

60+:

  1. Fall
  2. Confusional state
  3. Pain
  4. Sinus bradycardia (an unusually slow heartbeat due to heart disease)
  5. Anaemia (lack of blood)
  6. Asthenia (weakness)
  7. Bradycardia (abnormally slow heart action)
  8. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  9. Eye swelling
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 10.91%
  2. Pain: 5 people, 9.09%
  3. Depression: 5 people, 9.09%
  4. Fungal Nail Infection: 4 people, 7.27%
  5. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 4 people, 7.27%
  6. Psoriasis (immune-mediated disease that affects the skin): 3 people, 5.45%
  7. Fungal Infection: 3 people, 5.45%

* Approximation only. Some reports may have incomplete information.

Do you take Lopressor and Lamisil?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lopressor and Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lopressor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lamisil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lopressor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lamisil and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metoprolol tartrate and terbinafine hydrochloride (the active ingredients of Lopressor and Lamisil, respectively), and Lopressor and Lamisil (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: